Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Lowers Q1 2009 Guidance

NEW YORK (GenomeWeb News) – Agilent Technologies disclosed in a US Securities and Commission filing today that it has lowered its revenue and earnings-per-share guidance for its fiscal first quarter of 2009, which ends Jan. 31, 2009.
The firm said that due to “deteriorating economic conditions, particularly in electronic measurement markets,” it was lowering its revenue guidance to a range of between $1.25 billion and $1.3 billion. Last month, Agilent had predicted revenue of between $1.34 billion and $1.39 billion for the first quarter.
At that time, Agilent President and CEO Bill Sullivan said that the firm’s forecast for fiscal 2009 "is based on the assumption that an economic downturn in much of the world will continue through mid-2009, and that no geographies or markets will be entirely immune from its impact."
The company also lowered its EPS guidance for Q1 to a range of between $.28 and $.32, down from previous guidance of $.34 to $.38.
Agilent noted that the EPS guidance is non-GAAP and “excludes primarily the impacts of future restructuring and asset impairment charges and non-cash intangibles amortization.”
For the first quarter of 2008, Agilent brought in revenues of $1.39 billion and reported earnings per share of $.31.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.